Dr. Morgenstern is a healthcare consultant and subject matter expert for Booz Allen Hamilton at the Walter Reed National Military Medical Center in Bethesda, MD. He is president of the Optometric Council on Refractive Technology.
A peek into the history of the International Keratoconus Academy
Andrew Morgenstern, OD, FAAO, FNAP, gives a brief history of the International Keratoconus Academy of Eye Care Professionals.
IKA Keratoconus Symposium provides access to expert opinions, latest research
The goal of the inaugural International Keratoconus Academy (IKA) Keratoconus Symposium in Scottsdale, Arizona, was to help preserve vision.
IKA Keratoconus Symposium 2023: In-person white paper development, live patient Q&A
President and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.
International Keratoconus Academy continues to provide cutting-edge education
Over the years, IKA has become an invaluable resource for eye care professionals.
Role of Aceclidine in Presbyopia Treatment
Expert eye care specialists comment on the use of aceclidine as a selective miotic for the treatment of presbyopia.
Miotic Selectivity in the Management of Presbyopia
Andrew S. Morgenstern discusses the selectivity of miotic agents in isolating the pupil while limiting adverse events for the management of presbyopia.
Miotic Treatment Options for Presbyopia
Francis S. Mah, MD, reviews miotic agents that are available or under investigation for the treatment of presbyopia.
Targeting Pupil Size for Presbyopia Management
Andrew S. Morgenstern, OD, FAAO, FNAP, highlights the importance of reducing pupil size to a certain level to optimize near vision for patients with presbyopia.
Using Miotic Agents for the Management of Presbyopia
Expert eye care specialists discuss the role of miotic agents in targeting presbyopia in patients.
Impact of Presbyopia on Mechanism of Ocular Accommodation
Drs Andrew S. Morgenstern and Francis S. Mah provide insight on the functionality of ocular accommodation as an autofocus lens and how this is affected in patients with presbyopia.
Overview of Presbyopia
Francis S. Mah, MD, and Andrew S. Morgenstern, OD, FAAO, FNAP, review the impact of presbyopia on quality of life as well as current treatment options and unmet needs for disease management.
Treating and diagnosing myopia
Andrew Morgenstern, OD, FAAO, sits down to talk myopia in children and adults, how to treat it, and how to go prevent it at the American Optometric Association’s Optometry’s Meeting in Washington, DC.
Treating refractive error with corneal cross-linking
After much anticipation and a long wait for both clinicians and patients in need, the U.S. Food and Drug Administration (FDA) approved corneal cross-linking (CXL) in mid April. This procedure is globally considered the only method of halting the progressive family of diseases called corneal ectasias, including keratoconus.
How corneal biomechanics affects keratoconus and ectasia
In a landmark paper titled “Global consensus on keratoconus and ectatic diseases” published in the April 2015 issue of Cornea, Gomes et al sought to reach a consensus of the definition, concepts, clinical management, and surgical treatments of keratoconus and the family of corneal ectatic diseases.
2 Clarke Drive Cranbury, NJ 08512